QIAGEN Expands Bioinformatics Leadership with New Data Center in Asia-Pacific

QIAGEN Expands Bioinformatics Leadership with New Data Center in Asia-Pacific QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has officially opened a new data center in Melbourne, Australia, reinforcing its leadership in global bioinformatics, particularly in the Asia-Pacific region. This new…

Read MoreQIAGEN Expands Bioinformatics Leadership with New Data Center in Asia-Pacific

Prolific Machines Appoints Christina Perry as CFO to Drive Biopharmaceutical Growth

Prolific Machines Appoints Christina Perry as CFO to Drive Biopharmaceutical Growth Prolific Machines, a leading biotechnology company specializing in using light to control biological processes, has announced the appointment of Christina Perry as its new Chief Financial Officer (CFO). In…

Read MoreProlific Machines Appoints Christina Perry as CFO to Drive Biopharmaceutical Growth

Pfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer

Pfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer Pfizer Inc. (NYSE: PFE) has announced promising results from the Phase 3 TALAPRO-2 study, which tested TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with…

Read MorePfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer

GeneDx Launches 48-Hour Whole Genome Sequencing for Critical NICU and PICU Patients

GeneDx Launches 48-Hour Whole Genome Sequencing for Critical NICU and PICU Patients GeneDx (Nasdaq: WGS), a leader in genomic health insights, has unveiled ultraRapid Whole Genome Sequencing, providing quick, comprehensive genomic results for neonatal and pediatric patients in the NICU…

Read MoreGeneDx Launches 48-Hour Whole Genome Sequencing for Critical NICU and PICU Patients

HealthStream’s CredentialStream® Achieves HITRUST r2 Certification for Top Healthcare Data Security

HealthStream’s CredentialStream® Achieves HITRUST r2 Certification for Top Healthcare Data Security HealthStream (Nasdaq: HSTM), a leading healthcare technology provider for workforce solutions, announced today that its SaaS-based CredentialStream application, along with CredentialStream Hub and Network by HealthStream, has received HITRUST…

Read MoreHealthStream’s CredentialStream® Achieves HITRUST r2 Certification for Top Healthcare Data Security

Newleos Therapeutics Raises $93.5 Million in Oversubscribed Series A to Transform Neuropsychiatric Disorder Treatments

Newleos Therapeutics Raises $93.5 Million in Oversubscribed Series A to Transform Neuropsychiatric Disorder Treatments Newleos Therapeutics, Inc., a clinical-stage neuroscience company co-founded by Longwood Fund and experienced leaders in CNS drug development, has successfully closed an oversubscribed $93.5 million Series…

Read MoreNewleos Therapeutics Raises $93.5 Million in Oversubscribed Series A to Transform Neuropsychiatric Disorder Treatments

CharmHealth Launches Marketplace and Innovation Hub for Healthcare Ecosystem

CharmHealth Launches Marketplace and Innovation Hub for Healthcare Ecosystem CharmHealth, a leader in healthcare technology solutions for providers, today introduced the CharmHealthHub, a premium marketplace designed to connect a wide range of healthcare stakeholders, including providers, practice groups, patients, entrepreneurs,…

Read MoreCharmHealth Launches Marketplace and Innovation Hub for Healthcare Ecosystem

Ensoma Gets Pediatric Disease and Orphan Drug Designations for EN-374 in Chronic Granulomatous Disease

Ensoma Gets Pediatric Disease and Orphan Drug Designations for EN-374 in Chronic Granulomatous Disease Ensoma, a genomic medicines company focused on developing one-time, in vivo treatments to precisely and durably engineer the hematopoietic system, announced that the U.S. Food and…

Read MoreEnsoma Gets Pediatric Disease and Orphan Drug Designations for EN-374 in Chronic Granulomatous Disease